Overall rank by patents
#16,671
of 50,000 tracked assignees
USPTO PatentsView assignee record - 17 granted patents across 10 technology areas, recorded in grant years 2019–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06F (ELECTRIC DIGITAL DATA PROCESSING).
The verdict
According to USPTO PatentsView, Cellcontrol ranks #16,671 of 50,000 tracked US assignees by granted-patent volume, with 17 patents across 10 technology areas.
USPTO PatentsView assignee plate
Corpus R16671 · US Corporation #16,671 · 17 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Cane-line A/s (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Cellcontrol · this assignee
36 score
3D Lighting Innovati… · lowest
7 score
What this shows Cellcontrol, Inc. stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-THIN, CLAIMS-RICH, TYPE-USCORP, VEL-SURGE, BOOK-FULL. Volume places it #16,671 of 50,000; Innovation Score 36.3/100 sits in the top 47% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Cane-line A/s (±0 grants).
Cellcontrol, Inc. has been granted 17 US utility patents between 2019 and 2023, placing Cellcontrol, Inc. at #16,671 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.4 claims per patent with primary concentration in G06F (ELECTRIC DIGITAL DATA PROCESSING). As a US Corporation, Cellcontrol, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Cellcontrol sits between Cane-line A/s (17 patents, rank #16,663) and Chongqing Jinkang Powertrain NEW Energy Co., Ltd. (17 patents, rank #16,671) - the closest US assignees by grant volume. The composite Innovation Score of 36.3/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 14 grants, compared with 3 in the 2015–2019 window, a +367% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Cellcontrol, Inc.'s 17.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 10 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CANE-LINE A/S
17 patents
CARTER-HOFFMANN LLC
17 patents
CATHETER PRECISION, INC.
17 patents
CCS INC.
17 patents
CELLMAX TECHNOLOGIES AB
17 patents
CG Technology Development, LLC
17 patents
CHENGDU QIANNIUCAO INFORMATION TECHNOLOGY CO., LTD.
17 patents
CHONGQING JINKANG POWERTRAIN NEW ENERGY CO., LTD.
17 patents
CELLCONTROL, INC.
17 patents
What this shows Cellcontrol holds 17 patents at rank #16,667, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #16,667 in granted patent volume.
Other assignees with the most granted patents in Cellcontrol's primary technology class.
Cellcontrol's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
36 Top 47% higher than 53% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 3 | 17.6% |
| 2020 | 3 | 17.6% |
| 2021 | 4 | 23.5% |
| 2022 | 3 | 17.6% |
| 2023 | 4 | 23.5% |
Top 10 of 10 technology areas
Overall rank by patents
#16,671
of 50,000 tracked assignees
36.3 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.